In a recent study using a 3D model of tumor-associated ECM, we have shown that fibronectin in the tumor-associated ECM activates TLR4 signaling and IL-8 release in lung cancer cells (Cho et al., manuscript under review). This evidence concerns the gene CXCL8 and lung carcinoma.